Table of contents
Volume 99, Issue 2
Published online 15 July 2008 (225-384)
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Corrigenda
Clinical Studies
Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy
G Di Giuseppe, R Abbate, G Liguori, L Albano and I F Angelillo
Br J Cancer 99: 225-229; doi:10.1038/sj.bjc.6604454
Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
M Diaz, J J Kim, G Albero, S de Sanjosé, G Clifford, F X Bosch and S J Goldie
Br J Cancer 99: 230-238; advance online publication, July 8, 2008; doi:10.1038/sj.bjc.6604462
Do women 
50 years of age need as much screening as women <50 years after they have had negative screening results?
P Armaroli, F Gallo, A Bellomi, S Ciatto, D Consonni, D Davi, P Giorgi-Rossi, A Iossa, E Mancini, C Naldoni, E Polla, G Ronco, M Serafini, V Vergini, L Zanier, M Zappa and N Segnan
Br J Cancer 99: 239-244; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604455
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients
J P Koivunen, J Kim, J Lee, A M Rogers, J O Park, X Zhao, K Naoki, I Okamoto, K Nakagawa, B Y Yeap, M Meyerson, K-K Wong, W G Richards, D J Sugarbaker, B E Johnson and P A Jänne
Br J Cancer 99: 245-252; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604469
Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma
A R Clamp, W D J Ryder, S Bhattacharya, R Pettengell and J A Radford
Br J Cancer 99: 253-258; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604468
Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
A A M van der Veldt, E Boven, H H Helgason, M van Wouwe, J Berkhof, G de Gast, H Mallo, C N Tillier, A J M van den Eertwegh and J B A G Haanen
Br J Cancer 99: 259-265; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604456
Inequity in colorectal cancer treatment and outcomes: a population-based study
A-E Carsin, L Sharp, D P Cronin-Fenton, A Ó Céilleachair and H Comber
Br J Cancer 99: 266-274; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604467
UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study
D M Kweekel, H Gelderblom, T Van der Straaten, N F Antonini, C J A Punt and H-J Guchelaar
Br J Cancer 99: 275-282; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604461
Translational Therapeutics
Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2
B H Y Yeung, K Y Wong, M C Lin, C K C Wong, T Mashima, T Tsuruo and A S T Wong
Br J Cancer 99: 283-293; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604477
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
D M Ashley, C D Riffkin, M M Lovric, T Mikeska, A Dobrovic, J A Maxwell, H S Friedman, K J Drummond, A H Kaye, H K Gan, T G Johns and C J Hawkins
Br J Cancer 99: 294-304; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604459
FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer
S Nomura, H Yoshitomi, S Takano, T Shida, S Kobayashi, M Ohtsuka, F Kimura, H Shimizu, H Yoshidome, A Kato and M Miyazaki
Br J Cancer 99: 305-313; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604473
Molecular Diagnostics
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
G Attard, J Clark, L Ambroisine, I G Mills, G Fisher, P Flohr, A Reid, S Edwards, G Kovacs, D Berney, C Foster, C E Massie, A Fletcher, J S De Bono, P Scardino, J Cuzick and C S Cooper on behalf of the Transatlantic Prostate Group
Br J Cancer 99: 314-320; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604472
Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study
A Gaya, F Daley, N J Taylor, G Tozer, U Qureshi, A Padhani, R B Pedley, R Begent, D Wellsted, J J Stirling and G Rustin
Br J Cancer 99: 321-326; advance online publication, July 8, 2008; doi:10.1038/sj.bjc.6604426
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
S E Elsheikh, A R Green, E A Rakha, R M Samaka, A A Ammar, D Powe, J S Reis-Filho and I O Ellis
Br J Cancer 99: 327-334; advance online publication, July 8, 2008; doi:10.1038/sj.bjc.6604463
Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer
K Talvinen, J Tuikkala, O Nevalainen, A Rantanen, P Hirsimäki, J Sundström and P Kronqvist
Br J Cancer 99: 335-340; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604475
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
P de Graeff, A P G Crijns, K A ten Hoor, H G Klip, H Hollema, K Oien, J M Bartlett, G B A Wisman, G H de Bock, E G E de Vries, S de Jong and A G J van der Zee
Br J Cancer 99: 341-349; doi:10.1038/sj.bjc.6604471
MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer
S Suzuki, K Sasajima, Y Sato, H Watanabe, T Matsutani, S Iida, M Hosone, T Tsukui, S Maeda, K Shimizu and T Tajiri
Br J Cancer 99: 350-356; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604476
Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas
H K Tan, P Saulnier, A Auperin, L Lacroix, O Casiraghi, F Janot, P Fouret and S Temam
Br J Cancer 99: 357-363; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604478
Genetics and Genomics
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
F Lesueur, M de Lichy, M Barrois, G Durand, J Bombled, M-F Avril, A Chompret, F Boitier, G M Lenoir, French Familial Melanoma Study GroupB Bressac-de Paillerets
Br J Cancer 99: 364-370; advance online publication, July 8, 2008; doi:10.1038/sj.bjc.6604470
Rapid progression of prostate cancer in men with a BRCA2 mutation
S A Narod, S Neuhausen, G Vichodez, S Armel, H T Lynch, P Ghadirian, S Cummings, O Olopade, D Stoppa-Lyonnet, F Couch, T Wagner, E Warner, W D Foulkes, H Saal, J Weitzel, A Tulman, A Poll, R Nam and P Sun the Hereditary Breast Cancer Study Group
Br J Cancer 99: 371-374; advance online publication, June 24, 2008; doi:10.1038/sj.bjc.6604453
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma
T J Seng, N Currey, W A Cooper, C-S Lee, C Chan, L Horvath, R L Sutherland, C Kennedy, B McCaughan and M R J Kohonen-Corish
Br J Cancer 99: 375-382; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604452
Corrigenda
Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours FREE
K M Linton, Y Hey, E Saunders, M Jeziorska, J Denton, C L Wilson, R Swindell, S Dibben, C J Miller, S D Pepper, J A Radford and A J Freemont
Br J Cancer 99: 383; doi:10.1038/sj.bjc.6604506
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer FREE
H Suzuki, M Toyota, H Carraway, E Gabrielson, T Ohmura, T Fujikane, N Nishikawa, Y Sogabe, M Nojima, T Sonoda, M Mori, K Hirata, K Imai, Y Shinomura, S B Baylin and T Tokino
Br J Cancer 99: 384; doi:10.1038/sj.bjc.6604507
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.